Cambridge Nutritional Sciences plc
CNSL.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | £3,863 | £4,196 | £4,134 | £4,840 |
| % Growth | -7.9% | 1.5% | -14.6% | – |
| Cost of Goods Sold | £1,474 | £1,675 | £1,650 | £2,104 |
| Gross Profit | £2,389 | £2,521 | £2,484 | £2,736 |
| % Margin | 61.8% | 60.1% | 60.1% | 56.5% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £2,782 | £3,018 | £2,662 | £2,912 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £2,782 | £3,018 | £2,662 | £2,912 |
| Operating Income | -£393 | -£497 | -£178 | -£176 |
| % Margin | -10.2% | -11.8% | -4.3% | -3.6% |
| Other Income/Exp. Net | -£4 | £2,259 | -£18 | £0 |
| Pre-Tax Income | -£397 | £1,762 | -£196 | -£47 |
| Tax Expense | £0 | £0 | £0 | -£417 |
| Net Income | -£397 | £1,762 | -£196 | £370 |
| % Margin | -10.3% | 42% | -4.7% | 7.6% |
| EPS | -0.002 | 0.007 | -0.001 | 0.002 |
| % Growth | -123% | 1,025% | -150% | – |
| EPS Diluted | -0.002 | 0.007 | -0.001 | 0.002 |
| Weighted Avg Shares Out | 238,271 | 237,951 | 237,951 | 237,951 |
| Weighted Avg Shares Out Dil | 238,271 | 237,951 | 237,951 | 237,951 |
| Supplemental Information | – | – | – | – |
| Interest Income | £45 | £65 | £82 | £50 |
| Interest Expense | £7 | £8 | £9 | £10 |
| Depreciation & Amortization | £324 | £307 | £308 | £323 |
| EBITDA | -£66 | £2,077 | £121 | £286 |
| % Margin | -1.7% | 49.5% | 2.9% | 5.9% |